Erythropoietin
Orphan Drug Cold Chain RequiredFDA Approved
Description
Erythropoietin is a glycoprotein hormone that stimulates red blood cell production. It is used to treat anemia associated with chronic kidney disease and other conditions.
Indications & Therapeutic Use
Anemia associated with chronic kidney disease, Diamond-Blackfan anemia
Global Availability (4 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Erythropoietin
| Generic Name | Erythropoietin |
| Brands | 1 brand available |
| Active Ingredient | Epoetin alfa |
| Drug Class | Anemia associated with chronic kidney disease |
| Manufacturer | Amgen |
| Dosage Forms | Injection |
| Medical Code | B03XA01 |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Required |
| Lead Time | 14 days |
| Reg. Status | FDA Approved |
| Countries | 4 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations5 Validated Nodes